ANYGEN

Anijen Co., Ltd. is the first bio-venture company in Gwangju and Jeonnam province. Since its establishment in 2000, it has developed peptide biomaterial process and developed quality management technology. They are making efforts to advance into the global market based on their competitiveness. In 2016, it was listed on the KOSDAQ market based on its proprietary peptide biomaterials and new drug development technology. They are supplying Peptide Medicinal Materials of high quality, which have been approved by GMP for the first time in Korea, at a reasonable price in the peptides drug materials market, which is dominated by a small number of companies worldwide. This stabilizes the supply price of peptide drug raw materials, And contribute to the promotion of public health.